Table 1.
The clinical characteristics of the HCC patients in this study
| Characters | Categories | NO. |
|---|---|---|
| SEX | Female | 25 |
| Male | 139 | |
| Hepatitis | NONE | 22 |
| HBV | 138 | |
| HCV | 4 | |
| Alcohol habit(≥50g/day) | NO | 130 |
| YES | 34 | |
| High Blood pressure | NO | 144 |
| YES | 14 | |
| Type 2 Diabetes | NO | 144 |
| YES | 13 | |
| Family History | NO | 149 |
| YES | 15 | |
| Age (mean± SD) | 51.5±10.3 | |
| AFP (mean± SE) | 29481.7±14940.5 | |
| CEA (mean± SD) | 2.83±1.67 | |
| CA19-9 (mean± SE) | 33.4±5.57 | |
| Diameter of tumor (mean± SD) | 6.81±3.94 | |
| Fibrous Capsule | NO | 56 |
| YES | 108 | |
| Satellite Tumor | NO | 120 |
| YES | 44 | |
| Tumornecrosis | NO | 40 |
| YES | 124 | |
| Microvascular invasion | NO | 107 |
| YES | 57 | |
| Liver cirrhosis | None | 107 |
| Micronodular cirrhosis | 30 | |
| Mixed macro-micro-nodular cirrhosis | 24 | |
| Macronodular cirrhosis | 3 | |
| Architectural patterns | Thin trabecular pattern | 16 |
| Thicker trabecular pattern | 118 | |
| Other types | 30 | |
| TNM stage | < III | 19 |
| III | 139 | |
| > III | 6 |
AFP, serum alpha-fetoprotein; CEA, carcino-embryonic antigen.